Christopher L. Seiler

552 total citations
15 papers, 433 citations indexed

About

Christopher L. Seiler is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christopher L. Seiler has authored 15 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Christopher L. Seiler's work include Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Christopher L. Seiler is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Christopher L. Seiler collaborates with scholars based in United States, Germany and China. Christopher L. Seiler's co-authors include Natalia Tretyakova, Shaofei Ji, Iréne Esposito, Peter Schirmacher, Helmut Friess, Jörg Kleeff, Karin Müller‐Decker, Delshanee Kotandeniya, Sara Chiblak and Monica Tost and has published in prestigious journals such as Angewandte Chemie International Edition, Development and Biochemistry.

In The Last Decade

Christopher L. Seiler

15 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher L. Seiler United States 11 272 135 88 51 38 15 433
J. Rebecca Liu United States 14 321 1.2× 149 1.1× 26 0.3× 132 2.6× 19 0.5× 18 555
Sang Hyun Song South Korea 10 242 0.9× 82 0.6× 47 0.5× 59 1.2× 6 0.2× 22 396
T. Tsuruo Japan 10 255 0.9× 290 2.1× 66 0.8× 35 0.7× 6 0.2× 14 504
Nanya Wang China 13 150 0.6× 148 1.1× 37 0.4× 71 1.4× 10 0.3× 29 450
Christina Economopoulou Greece 8 221 0.8× 73 0.5× 15 0.2× 58 1.1× 13 0.3× 15 401
Dae-Ghon Kim South Korea 11 276 1.0× 86 0.6× 39 0.4× 150 2.9× 8 0.2× 12 422
Yujin Wang China 12 154 0.6× 81 0.6× 18 0.2× 106 2.1× 8 0.2× 22 319
C. Vanesa Díaz-García Spain 10 180 0.7× 111 0.8× 49 0.6× 121 2.4× 4 0.1× 18 330
P. Godwin Ireland 4 173 0.6× 88 0.7× 39 0.4× 97 1.9× 6 0.2× 6 330
Qingxia Xu China 11 179 0.7× 41 0.3× 27 0.3× 76 1.5× 14 0.4× 35 314

Countries citing papers authored by Christopher L. Seiler

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Seiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Seiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Seiler more than expected).

Fields of papers citing papers by Christopher L. Seiler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Seiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Seiler. The network helps show where Christopher L. Seiler may publish in the future.

Co-authorship network of co-authors of Christopher L. Seiler

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Seiler. A scholar is included among the top collaborators of Christopher L. Seiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Seiler. Christopher L. Seiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Xiaohong, Aaron L. Sarver, Christopher L. Seiler, et al.. (2022). UHRF2 regulates cell cycle, epigenetics and gene expression to control the timing of retinal progenitor and ganglion cell differentiation. Development. 149(6). 10 indexed citations
2.
Seiler, Christopher L., Juan Song, Delshanee Kotandeniya, et al.. (2020). Inhalation exposure to cigarette smoke and inflammatory agents induces epigenetic changes in the lung. Scientific Reports. 10(1). 11290–11290. 29 indexed citations
3.
Kono, Thomas J. Y., Charles G. Knutson, N. Parry, et al.. (2020). Multi-Omics Characterization of Inflammatory Bowel Disease-Induced Hyperplasia/Dysplasia in the Rag2−/−/Il10−/− Mouse Model. International Journal of Molecular Sciences. 22(1). 364–364. 14 indexed citations
4.
Seiler, Christopher L., Jung Min Song, Jenna Fernandez, et al.. (2019). Epigenetic Changes in Alveolar Type II Lung Cells of A/J Mice Following Intranasal Treatment with Lipopolysaccharide. Chemical Research in Toxicology. 32(5). 831–839. 11 indexed citations
5.
Matter, Brock, Christopher L. Seiler, Xun Ming, et al.. (2018). Mapping three guanine oxidation products along DNA following exposure to three types of reactive oxygen species. Free Radical Biology and Medicine. 121. 180–189. 23 indexed citations
7.
Kotandeniya, Delshanee, Christopher L. Seiler, Jenna Fernandez, et al.. (2018). Can 5-methylcytosine analogues with extended alkyl side chains guide DNA methylation?. Chemical Communications. 54(9). 1061–1064. 10 indexed citations
8.
Ji, Shaofei, et al.. (2017). Reversible DNA–Protein Cross‐Linking at Epigenetic DNA Marks. Angewandte Chemie International Edition. 56(45). 14130–14134. 73 indexed citations
9.
Pang, Jiuxia, Na Shen, Fei Yan, et al.. (2017). Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells. Oncotarget. 8(21). 34453–34467. 48 indexed citations
10.
Ji, Shaofei, et al.. (2017). Reversible DNA–Protein Cross‐Linking at Epigenetic DNA Marks. Angewandte Chemie. 129(45). 14318–14322. 14 indexed citations
11.
Wickramaratne, Susith, Christopher L. Seiler, & Natalia Tretyakova. (2015). Synthesis of DNA Oligodeoxynucleotides Containing Site‐Specific 1,3‐Butadiene‐ Deoxyadenosine Lesions. Current Protocols in Nucleic Acid Chemistry. 61(1). 4.61.1–4.61.22. 3 indexed citations
12.
Seiler, Christopher L., et al.. (2013). Identification of new inhibitors for low molecular weight protein tyrosine phosphatase isoform B. Bioorganic & Medicinal Chemistry Letters. 23(21). 5912–5914. 5 indexed citations
13.
Shi, Ce, Divya Tiwari, Daniel J. Wilson, et al.. (2013). Bisubstrate Inhibitors of Biotin Protein Ligase in Mycobacterium tuberculosis Resistant to Cyclonucleoside Formation. ACS Medicinal Chemistry Letters. 4(12). 1213–1217. 32 indexed citations
14.
Aichler, Michaela, Christopher L. Seiler, Monica Tost, et al.. (2011). Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. The Journal of Pathology. 226(5). 723–734. 89 indexed citations
15.
Esposito, Iréne, et al.. (2007). Hypothetical Progression Model of Pancreatic Cancer With Origin in the Centroacinar-Acinar Compartment. Pancreas. 35(3). 212–217. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026